CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Bylaws or fiscal year change
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Executive Officer bought 700 shares at an average $1.59 ($1,115)
- 4 Open-market buy Chief Executive Officer bought 1,700 shares at $1.17 ($1,989)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $1.27 ($635)
- 4 Open-market buy Chief Executive Officer bought 300 shares at $1.39 ($417)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $1.36 ($1,360)
- 4 Open-market buy Chief Executive Officer bought 4,400 shares at an average $1.32 ($5,818)
- 4 Open-market buy Chief Executive Officer bought 7,000 shares at $1.26 ($8,820)
- 8-K Event Regulation FD disclosure
Page 5 of 31 · 605 filings